News & Updates
Filter by Specialty:
Show Multimedia Only

Pulmonary arterial hypertension outcomes better with early therapy augmentation with selexipag
04 Oct 2024
    byJairia Dela Cruz
        In the treatment of patients with pulmonary arterial hypertension, adding selexipag as a third medication sooner rather than later is crucial to help prevent hospitalization and disease progression, as suggested in an emulated target trial.
Pulmonary arterial hypertension outcomes better with early therapy augmentation with selexipag
04 Oct 2024
Novel AI tool for predicting cardio-cerebrovascular disease risk among Chinese
03 Oct 2024
    byElaine Tan
        Researchers at the University of Hong Kong (HKU) have developed an innovative artificial intelligence (AI) assessment model that has the potential to fundamentally change the prevention and management of cardio-cerebrovascular (CCV) diseases specifically in the Chinese population.







